Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial
Cullen M. Taniguchi, Jessica M. Frakes, Todd A. Aguilera, Manisha Palta, Brian G. Czito, Manoop S. Bhutani, Lauren E. Colbert, Joseph Abi Jaoude, Vincent Bernard, Shubham Pant, Ching‐Wei D. Tzeng, Dae Won Kim, Mokenge P. Malafa, James Costello, Geena Mathew, Neal Rebueno, Eugene J. Koay, Prajnan Das, Ethan B. Ludmir, Matthew H. G. Katz, Robert A. Wolff, Sam Beddar, Gabriel O. Sawakuchi, Shalini Moningi, Rebecca S. Tidwell, Ying Yuan, Peter F. Thall, Robert A. Beardsley, Jon Holmlund, Joseph M. Herman, Sarah E. Hoffe
Topics & Concepts
PlaceboMedicineDouble blindPancreatic ductal adenocarcinomaPhase (matter)Internal medicineOncologyPancreatic cancerPathologyCancerChemistryAlternative medicineOrganic chemistryPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesHepatocellular Carcinoma Treatment and Prognosis